Close to 60 players, worldwide, have taken initiatives to develop exosome therapeutics; the market is characterized by the presence of start-ups and small companies, claims Roots Analysis
Driven by the development of novel platforms and advanced technologies along with consistent efforts of the stakeholders in research and development of exosome therapeutics which is set to see some FDA approved therapies in this decade
A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):
- Type of Therapeutic
- Allogeneic Therapy
- AutologousTherapy
- Target Indication(s)
- Degenerative Meniscal Injury
- Dystrophic Epidermolysis Bullosa
- Fistula Perianal
- Retinitis Pigmentosa
- Therapeutic Area
- Dermatological Disorders
- Muscoskeletal Disorders
- Ophthalmic Diseases
- Rectal Disorders
- Route of Administration
- Fistula Tract
- Intra-articular
- Intra-ocular
- Geography
- North America
- Europe
- Asia-Pacific and Rest of the World
The Exosome Therapeutics Market, 2022-2040 report features the following companies, which we identified to be key players in this domain:
- Codiak BioSciences
- Coya Therapeutics
- Curexsys
- EV Therapeutics
- Evox Therapeutics
- SHIFTBIO
- AEGLE Therapeutics
- AVEM Healthcare
- Cellular Biomedicine Group
- OBCTCD24
- ReNeuron
- Stem Cell Medicine
Table of Contents
- Preface
2. Executive Summary
Introduction- Market Landscape
- Company Profiles
- Drug Profiles
- Clinical Trial Analysis
- Academic Grants Analysis
- Global Event Analysis
- Partnerships and Collaborations
- Funding and Investments
- Start-up Health Indexing
- Case Study: Exosome Development and Manufacturing Service Providers
- Drug Failure Analysis
- Market Forecast
- Executive Insights
- Appendix 1: Tabulated Data
- Appendix 2: List of Companies and Organizations
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/exosome-therapeutics-market.html
You may also be interested in the following titles:
| Decentralized Clinical Trials / Virtual Clinical Trials Market |
You may also like to learn what our experts are sharing in Roots educational series:
| Antiviral Drugs Development: Are we Prepared for the Next Viral Pandemic? |
| Exploring How Artificial Intelligence Is Transforming Digital Pathology |
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415